ErbB2 regulates cysteine cathepsins B and L in human breast cancer

被引：0
作者：
Rafn, Bo [1 ]
机构：
[1] Danish Canc Soc, Copenhagen, Zealand, Denmark
来源：
CLINICAL & EXPERIMENTAL METASTASIS | 2011年 / 28卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：234 / 234
页数：1
相关论文
共 50 条
[31]   Nucleolin and ErbB2 inhibition reduces tumorigenicity of ErbB2-positive breast cancer [J].
Wolfson, Eya ;
Solomon, Shira ;
Schmukler, Eran ;
Goldshmit, Yona ;
Pinkas-Kramarski, Ronit .
CELL DEATH & DISEASE, 2018, 9
[32]   Clinical and genomic landscape of ERBB2 and ERBB3 mutated breast cancer [J].
Bilani, Nadeem ;
Tao, Jacqueline ;
Safonov, Anton ;
Casey, Dana ;
Drago, Joshua ;
Ahmed, Mehnaj ;
Acevedo, Barbara ;
Jhaveri, Komal ;
Reis-Filho, Jorge ;
Robson, Mark ;
Toska, Eneda ;
Hanker, Ariella ;
Arteaga, Carlos ;
Chandarlapaty, Sarat ;
Wen, Hanna Y. ;
Razavi, Pedram .
CANCER RESEARCH, 2024, 84 (09)
[33]   Dual targeting of ErbB1 and ErbB2 enhances response to chemotherapy in ErbB2 overexpressing breast cancer cell lines. [J].
O'Donovan, N. ;
Clynes, M. ;
Crown, J. .
BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 :S105-S105
[34]   Anti-oestrogen stimulation of ERBB2 ectodomain shedding from BT-474 human breast cancer cells with ERBB2 gene amplification [J].
Warri, AM ;
Isola, JJ ;
Harkonen, PL .
EUROPEAN JOURNAL OF CANCER, 1996, 32A (01) :134-140
[35]   Direct resequencing of the complete ERBB2 coding sequence reveals an absence of activating mutations in ERBB2 amplified breast cancer [J].
Zito, Christina I. ;
Riches, David ;
Kolmakova, Julia ;
Simons, Jan ;
Egholm, Michael ;
Stern, David F. .
GENES CHROMOSOMES & CANCER, 2008, 47 (07) :633-638
[36]   Identification of ErbB2 function in the heart: implication for anti-ErbB2 therapy in breast cancer [J].
Perry, M-C ;
Eichner, L. J. ;
Dufour, C. R. ;
Muller, W. J. ;
Giguere, V. .
CANCER RESEARCH, 2012, 72
[37]   Nucleolin-binding by ErbB2 enhances tumorigenicity of ErbB2-positive breast cancer [J].
Wolfson, Eya ;
Goldenberg, Maria ;
Solomon, Shira ;
Frishberg, Amit ;
Pinkas-Kramarski, Ronit .
ONCOTARGET, 2016, 7 (40) :65320-65334
[38]   Discovery of somatic ERBB2 mutations in human gallbladder cancer [J].
Iyer, P. ;
Gardi, N. ;
Ranjan, M. ;
Chandrani, P. ;
Upadhyay, P. ;
Ramadwar, M. R. ;
Shrikhande, S. V. ;
Dutt, A. .
EUROPEAN JOURNAL OF CANCER, 2016, 54 :S55-S55
[39]   Genetic immunization against neu/erbB2 transgenic breast cancer [J].
Amici, A ;
Venanzi, FM ;
Concetti, A .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1998, 47 (04) :183-190
[40]   Gankyrin is frequently overexpressed in breast cancer and is associated with ErbB2 expression [J].
Kim, Yeong Hwa ;
Kim, Jang-Hee ;
Choi, Yong Won ;
Lim, Seo Kyung ;
Yim, Hyunee ;
Kang, Seok Yun ;
Chung, Yong Sik ;
Lee, Ga-Young ;
Park, Tae Jun .
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2013, 94 (02) :360-365
12345